[Long-acting antiparkinson agents. I. Pilot study on benzetimide (342 cases)].
D000293:Adolescent; D000328:Adult; D000368:Aged; D001593:Benzyl Compounds / Q000627:therapeutic use; D005116:Extrapyramidal Tracts / Q000187:drug effects; D006801:Humans; D008875:Middle Aged; D009069:Movement Disorders / Q000139:chemically induced; D010276:Parasympatholytics / Q000008:administration & dosage / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy*; D011352:Procyclidine / Q000627:therapeutic use; D011728:Pyridones / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors; D014149:Tranquilizing Agents / Q000009:adverse effects
D001593:Benzyl Compounds; D010276:Parasympatholytics; D011728:Pyridones; D014149:Tranquilizing Agents; D011352:Procyclidine
Antiparkinsoniens à longue durée d'action. I. Etude pilote de la benzetimide (342 cas.